ChemT Biotechnology
PrivateLast Round
Seed
Jun 22, 2026
Total Funding Raised
$5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ChemT Biotechnology operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Seed round in June 2026.
ChemT Biotechnology is a biotechnology company that provides an AI-driven virtual cell platform, CelMo™, to improve the manufacturing of biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ChemT Biotechnology Comparables
Compare ChemT Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iOrganBio | 81% | |
| Tolemy Bio | 78% | |
| BoutIQ Solutions | 74% |
For institutional investors. Book with your work email.
ChemT Biotechnology Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ChemT Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Draper University Ventures | Seed |
| SEEDS Capital | Seed |
| Wavemaker Three-Sixty Health | Seed |
| Temasek Lifesciences Accelerator | Seed |
| Wavemaker Ventures | Seed |
| Wavemaker Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Grew 43% QoQ, from 7 to 10 employees.
- Aug 1, 2026
Open roles increased to 2, 3x the trailing average.
For institutional investors. Book with your work email.
ChemT Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ChemT Biotechnology's valuation, stock price, and market status.
Is ChemT Biotechnology a public or private company?
ChemT Biotechnology is a private company.
What is the current stock price of ChemT Biotechnology?
ChemT Biotechnology is a private company, so its shares have no public market price. Caplight tracks ChemT Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ChemT Biotechnology worth (valuation)?
Valuation information for ChemT Biotechnology is not publicly available.
Can I buy ChemT Biotechnology stock?
ChemT Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ChemT Biotechnology's last funding round?
ChemT Biotechnology's most recent funding round was Seed on June 22, 2026.
Who are the main investors in ChemT Biotechnology?
Key investors in ChemT Biotechnology include SEEDS Capital, Wavemaker Ventures, Wavemaker Partners.
Will ChemT Biotechnology IPO soon?
No public IPO plans have been announced for ChemT Biotechnology.
How can I track ChemT Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in ChemT Biotechnology's shares on secondary markets.